By expenditures
| Name | Title | Type |
|---|---|---|
| Jennifer Dement | Vice President, Finance & Administration | Auditee |
| Julie Fahey | PARTNER | Auditee |
| Kristin Diggs | Partner | Auditee |
| Dan Miley | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 385231 | 2025 | 2026-02-03 | EIDE BAILLY LLP | $35.13M |
| 337161 | 2024 | 2025-01-10 | Eide Bailly LLP | $30.35M |
| 14137 | 2023 | 2024-01-29 | Talbot Korvola & Warwick LLP | $29.61M |
| 24635 | 2022 | 2022-12-28 | Talbot Korvola & Warwick LLP | $42.34M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 385231 | 2025 | 2026-02-03 | 1172101 | 2025-003 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172100 | 2025-003 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172099 | 2025-003 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172098 | 2025-003 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172097 | 2025-002 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172096 | 2025-002 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172095 | 2025-002 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172094 | 2025-002 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172093 | 2025-001 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172092 | 2025-001 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172091 | 2025-001 | Material Weakness | Yes | N |
| 385231 | 2025 | 2026-02-03 | 1172090 | 2025-001 | Material Weakness | Yes | N |
| 337161 | 2024 | 2025-01-10 | 1095152 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 1095151 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 1095150 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 1095149 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 1095148 | 2024-002 | Significant Deficiency | - | N |
| 337161 | 2024 | 2025-01-10 | 1095147 | 2024-002 | Significant Deficiency | - | N |
| 337161 | 2024 | 2025-01-10 | 1095146 | 2024-002 | Significant Deficiency | - | N |
| 337161 | 2024 | 2025-01-10 | 1095145 | 2024-002 | Significant Deficiency | - | N |
| 337161 | 2024 | 2025-01-10 | 518710 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 518709 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 518708 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 518707 | 2024-003 | Significant Deficiency | - | L |
| 337161 | 2024 | 2025-01-10 | 518706 | 2024-002 | Significant Deficiency | - | N |
| 337161 | 2024 | 2025-01-10 | 518705 | 2024-002 | Significant Deficiency | - | N |
| 337161 | 2024 | 2025-01-10 | 518704 | 2024-002 | Significant Deficiency | - | N |
| 337161 | 2024 | 2025-01-10 | 518703 | 2024-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 586917 | 2023-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 586916 | 2023-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 586915 | 2023-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 586914 | 2023-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 10475 | 2023-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 10474 | 2023-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 10473 | 2023-002 | Significant Deficiency | - | N |
| 14137 | 2023 | 2024-01-29 | 10472 | 2023-002 | Significant Deficiency | - | N |
| 24635 | 2022 | 2022-12-28 | 597941 | 2022-002 | Material Weakness | - | L |
| 24635 | 2022 | 2022-12-28 | 21499 | 2022-002 | Material Weakness | - | L |